RxDoctor Payments Data

Brian Story, MD

Gastroenterology · Meridian, IDNPI 1851551089

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.7% of the total across 79 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 32.3% of the total. Reporting peaked in 2019 at $811 and has fallen 85.5% since, to $118 in 2025.

$2,115in general payments, 2019–2025

Across 79 payments — averaging $26.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$683
  • QOL Medical, LLC$385
  • Takeda Pharmaceuticals U.S.A., Inc.$184
  • Medtronic$137
  • Johnson & Johnson$121
  • Ambu Inc.$90
  • plus $514 from 16 others

What the payments were for

  • Food & beverage$2,02596%
  • Education$904%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,115 in reported general payments places this provider in the 60th percentile of 70 gastroenterology providers in Idaho.

See all gastroenterology providers in Idaho

Medicare billing

Part B allowed, 2024
$99,254
Medicare patients
410
Services billed
1,270

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates272$17,395
Mesalamine15$8,986
Omeprazole138$2,332
Ursodiol14$2,197
Azathioprine51$1,543
Ondansetron OdtOndansetron319$1,308
Esomeprazole Magnesium20$1,020
Sucralfate19$891
Pantoprazole Sodium29$673
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl36$539
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl36$428
Dicyclomine Hcl29$398
Promethazine Hcl19$222
Sulfasalazine11$199
Sodium Chloride0.9 % Sodium Chloride11$73

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Meridian

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →